These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34615853)

  • 1. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer.
    Zhu H; Su Z; Ning J; Zhou L; Tan L; Sayed S; Song J; Wang Z; Li H; Sun Q; Liu S; Sha O; Leng F; Chen X; Lu D
    Cell Death Dis; 2021 Oct; 12(10):912. PubMed ID: 34615853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells.
    Yu S; Wang Z; Su Z; Song J; Zhou L; Sun Q; Liu S; Li S; Li Y; Wang M; Zhang GQ; Zhang X; Liu ZJ; Lu D
    BMC Complement Altern Med; 2018 Feb; 18(1):59. PubMed ID: 29444668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
    Lu W; Lin C; Li Y
    Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6.
    Dong Y; Zhang Y; Kang W; Wang G; Chen H; Higashimori A; Nakatsu G; Go M; Tong JH; Zheng S; To KF; Sung JJ; Yang X; Ng SS; Yu J
    Theranostics; 2019; 9(22):6517-6531. PubMed ID: 31588233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
    Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
    J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
    Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
    PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
    Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
    Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
    Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.
    Mao D; Zhang X; Wang Z; Xu G; Zhang Y
    Hum Cell; 2022 Sep; 35(5):1535-1546. PubMed ID: 35907137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration.
    Marastoni S; Andreuzzi E; Paulitti A; Colladel R; Pellicani R; Todaro F; Schiavinato A; Bonaldo P; Colombatti A; Mongiat M
    J Pathol; 2014 Mar; 232(4):391-404. PubMed ID: 24374807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfur-Coordinated Organoiridium(III) Complexes Exert Breast Anticancer Activity via Inhibition of Wnt/β-Catenin Signaling.
    Sun Q; Wang Y; Fu Q; Ouyang A; Liu S; Wang Z; Su Z; Song J; Zhang Q; Zhang P; Lu D
    Angew Chem Int Ed Engl; 2021 Feb; 60(9):4841-4848. PubMed ID: 33244858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer.
    Xiong Y; Zhou L; Su Z; Song J; Sun Q; Liu SS; Xia Y; Wang Z; Lu D
    Onco Targets Ther; 2019; 12():993-1005. PubMed ID: 30787621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.
    Lu W; Li Y
    J Cell Biochem; 2014 Oct; 115(10):1799-807. PubMed ID: 24905570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung.
    Zhang J; Chen J; Wo D; Yan H; Liu P; Ma E; Li L; Zheng L; Chen D; Yu Z; Liang C; Peng J; Ren DN; Zhu W
    Clin Cancer Res; 2019 Aug; 25(15):4832-4845. PubMed ID: 31010839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Wnt Co-Receptor LRP6 in Triple Negative Breast Cancer Cell Migration and Invasion.
    Ma J; Lu W; Chen D; Xu B; Li Y
    J Cell Biochem; 2017 Sep; 118(9):2968-2976. PubMed ID: 28247948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
    Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
    Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor promoter TPA activates Wnt/β-catenin signaling in a casein kinase 1-dependent manner.
    Su Z; Song J; Wang Z; Zhou L; Xia Y; Yu S; Sun Q; Liu SS; Zhao L; Li S; Wei L; Carson DA; Lu D
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7522-E7531. PubMed ID: 30038030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy.
    Liu CC; Prior J; Piwnica-Worms D; Bu G
    Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5136-41. PubMed ID: 20194742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling.
    Zhang Y
    Biochem Biophys Res Commun; 2017 Jul; 488(4):679-684. PubMed ID: 28427938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.